Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-06

Clinical Trial Update: A Study of Ataluren in Pediatric Participants With Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial update of ataluren in pediatric cystic fibrosis participants completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ataluren (ataluren)

Snippet

Sponsor: PTC Therapeutics | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2020-03-06